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Patterns of seizure control in patients with
mesial temporal lobe epilepsy with and
without hippocampus sclerosis
Padrões de controle de crises em pacientes com epilepsia de lobo temporal com ou sem
esclerose hipocampal
Ana Carolina Coan, Brunno M. Campos, Felipe P.G Bergo, Bruno Y. Kubota, Clarissa L. Yasuda, Marcia
E. Morita, Carlos A.M Guerreiro, Fernando Cendes
ABSTRACT
Objective: Patients with mesial temporal lobe epilepsy (MTLE) may present unstable pattern of seizures. We aimed to evaluate
the occurrence of relapse-remitting seizures in MTLE with (MTLE-HS) and without (MTLE-NL) hippocampal sclerosis. Method: We
evaluated 172 patients with MTLE-HS (122) or MTLE-NL (50). Relapse-remitting pattern was defined as periods longer than two years of
seizure-freedom intercalated with seizure recurrence. “Infrequent seizures” was considered as up to three seizures per year and “frequent
seizures” as any period of seizures higher than that. Results: Thirty-seven (30%) MTLE-HS and 18 (36%) MTLE-NL patients had
relapse-remitting pattern (X2, p = 0.470). This was more common in those with infrequent seizures (X2, p, 0.001). Twelve MTLE-HS and one
MTLE-NL patients had prolonged seizure remission between the first and second decade of life (X2, p = 0.06). Conclusion: Similar proportion
of MTLE-HS or MTLE-NL patients present relapse-remitting seizures and this occurs more often in those with infrequent seizures.
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RESUMO
Objetivo: Pacientes com epilepsia do lobo temporal mesial (ELTM) podem apresentar padrão instável de crises epilépticas. Nosso objetivo
foi avaliar ocorrência de crises remitente-recorrentes em ELTM com (ELTM-EH) e sem (ELTM-NL) esclerose hipocampal. Método:
Avaliamos 172 pacientes com ELTM-EH (122) ou ELTM-NL (50). Padrão remitente-recorrente foi definido como períodos superiores a dois
anos de remissão intercalados com recorrência de crises. Até três crises por ano foram consideradas como "infrequentes" e qualquer
período com frequência maior como "frequentes". Resultados: Trinta e sete (30%) pacientes com ELTM-EH e 18 (36%) com ELTM-NL
apresentaram crises remitente-recorrentes (X2, p = 0,470), mais comum naqueles com crises infrequentes (X2, p , 0,001). Doze pacientes
com ELTM-EH e um ELTM-NL apresentaram remissão prolongada de crises entre a primeira e a segunda década de vida (X2, p = 0,06).
Conclusão: Proporção semelhante de pacientes com ELTM-EH e ELTM-NL apresentam crises remitente-recorrentes e isso ocorre com
maior frequência em pacientes com crises esporádicas.
Palavras-chave: epilepsia, lobo temporal, convulsões.
Patients with epilepsy may present an unstable pattern of
seizure control under antiepileptic drugs (AEDs) treatment,
which may be inherent to the underlying pathophysiology
of the disease.
Population-based studies demonstrate that nearly two-
thirds of patients with epilepsy will achieve seizure remission
under AED treatment1. Although the majority of patients will
have a stable pattern of response to the medications through
long-term follow-ups, an intermittent pattern with refractory
seizures interrupted by periods of remission can occur2. It
has been estimated that around 16% of patients with epi-
lepsies will have a relapse-remitting course, intercalating
periods of seizure remission and refractory seizures3. It is
also current knowledge that the underlying cause of the epi-
lepsy is the major contributor to define AED response4. The
role of possible different aetiologies to the occurrence of
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relapse-remitting patterns of seizure control has not been
properly delineated.
Mesial temporal lobe epilepsy (MTLE) is the most com-
mon epileptic syndrome in adults and is most often asso-
ciated with hippocampal sclerosis (HS)5. The natural
history of MTLE-HS has been extensively studied6,7.
However, the natural history of MTLE with different
underlying causes, especially MTLE in patients with normal
MRI, is still not fully understood. Although relapse-remitting
patterns of seizure control has been described in MTLE,
its frequency in different studies is variable8 and the role
of the presence of HS or other underlying pathology in
this pattern of AED response has not been properly
examined.
The objective of the present study was to evaluate and
compare the patterns of seizure control across the lifespan
of patients with MTLE with and without MRI signs of HS.
METHOD
Patients’ selection and classification
We retrospectively evaluated the clinical data of 172 con-
secutive patients with clinical and electroencephalographic
diagnosis of MTLE followed in a tertiary epilepsy centre
(Epilepsy Clinic of Campinas State University).
All patients had either MTLE associated with HS (MTLE-
HS) or MTLE of unknown origin (MTLE with normal MRI,
MTLE-NL). Patients with MTLE of other etiologies (tumor,
vascular, cortical malformations) were not selected. All
patients signed Informed Consent approved by the Ethics
Committee of Universidade Estadual de Campinas prior to
the acquisition of MRI.
For the definition of signs of HS, MRIs were acquired in a 3
Tesla Philips Intera Achieva scanner (Philips, Best, Netherlands)
between August 2009 and June 2012. The MRI protocol
included 3D-T1 weighted images (isotropic voxels of 1 mm,
acquired in the sagittal plane; 1 mm thick, flip angle = 8°,
TR = 7.0 ms, TE = 3.2 ms, matrix = 240 x 240, FOV = 240 x 240),
T2 weighted image multi-eco coronal images (3 mm thick,
TR = 3300 ms, TE = 30/60/90/120/150 ms, matrix = 200 x 180,
FOV = 180 x 180), as well as 3 mm thick coronal T1-inversion
recovery and fluid attenuated inversion recovery (FLAIR) per-
pendicular to the long axis of hippocampus. HS signs were
defined by MRI visual analysis plus MRI quantification of hip-
pocampus volume and T2 signal, as described in a previous
publication9. According to these analyses, patients were clas-
sified as MRI signs of HS (MTLE-HS, N = 122) or normal MRI
(TLE-NL, N = 50).
Clinical data and definitions
The long-term seizure control pattern of each patient
was assessed from the seizure onset period.
Patients were considered as relapse-remitting pattern of
seizure control if they presented at least one period equal
or longer than two years without any type of epileptic seiz-
ure intercalated with periods of seizure recurrence.
Independently from the classification of patients with or
without relapse-remitting pattern, patients were divided in
two groups according to the seizure frequency across the life
spam. According to the frequency of seizures, patients were
considered as having infrequent seizures if after achieving
the adequate dose of the first AED they presented only sim-
ple partial seizures (SPS) or up to three complex partial sei-
zures (CPS) per year and no generalized tonic-clonic seizures
(GTCS). Patients with any period of seizures higher than that
were considered as having frequent seizures.
RESULTS
There was no difference of sex or age distribution at the
moment of the MRI acquisition between MTLE-HS and
MTLE-NL patients. All patients had been under at least
two different AEDs in optimized doses since the epilepsy
onset. Detailed clinical information of the groups of patients
is shown in Table.
Thirty-seven (30%) MTLE-HS patients and 18 (36%)
MTLE-NL had a relapse-remitting pattern and no difference
in the frequency of relapse-remitting pattern was observed
between the groups (X2, p = 0.470).
In the MTLE-HS group, 104 (85%) were classified as
frequent seizures and 19% (20/104) of those had relapse-
remitting pattern while 18 (15%) were classified as
infrequent seizures and 94% (17/18) of those had relapse-
remitting pattern. In MTLE-NL group, 38 (76%) were clas-
sified as frequent seizures and 18% (7/38) of those had
relapse-remitting pattern while 12 (24%) were classified as
infrequent seizures and 92% (11/12) of those had relapse-
remitting pattern. There was no difference in the distri-
bution of the seizure frequency in the MTLE-HS and
MTLE-NL groups (X2, p = 0.146). Among all patients with
infrequent seizures, 93% (28/30) had relapse-remitting pat-
tern while it only occurred in 19% (27/142) of patients with
frequent seizures (X2, p , 0.001). Twelve (10%) MTLE-HS
patients had a prolonged period (more than five years) of
seizure remission between the first and the second decade
of life and it only occurred in only one patient with
MTLE-NL and there was a trend in favour of patients with
MTLE-HS for the occurrence of this pattern (X2, p = 0.06).
At the moment of the MRI acquisition, 13 (11%) patients
with MTLE-HS were free of seizures for a period equal or
longer than two years (medium of three years of seizure-free-
dom, ranging from two to nine years). In this group, the
medium time from the epilepsy onset to the present seizure
remission was 22 years (ranging from three to 56 years). In
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MTLE-NL group, ten (21%) were free of seizures for a period
equal or longer than two years (medium of three years of
seizure-freedom, ranging from two to six years). For
MTLE-NL patients, the medium time from the epilepsy
onset to the present seizure remission was 16 years (ranging
from four to 38 years). There was no difference in the fre-
quency of present seizure remission between MTLE-HS
and MTLE-NL groups (X2, p = 0.102).
DISCUSSION
In this study, we evaluated the patterns of seizure control
across the lifespan of patients with MTLE with and without
MRI signs of HS and we observed that:
N A pattern of relapse-remitting seizures occurs in nearly
one-third of patients with MTLE, independent of the
presence of MRI signs of HS or normal MRI;
N In both MTLE-HS and MTLE-NL, the relapse-remitting
pattern occurs more often in patients with infrequent
seizures.
MTLE is not a single entity, but a group of different con-
ditions that share common clinical and neurophysiologic
characteristics10. In MTLE, it is known that different aetiolo-
gies imply diverse long-term outcomes, with MTLE-HS being
the subtype with the higher rates of drug-resistant seizures4.
The knowledge of the natural history of the different types of
MTLEs, including long-term response to AEDs, has import-
ant implications in the individual decisions for adequate
choices of treatments. Moreover, it is also important for
the understanding of the characteristics that lead different
patients to infrequent or frequent seizures.
The ILAE consensus defines drug-resistant epilepsy as
the failure of adequate trials of two tolerated and appropri-
ately chosen AED schedules11. According to this definition,
all patients included in the present study could be classified
as refractory during one or different periods of their epilepsy
evolution once all failed at least two different AEDs. Even
those with current seizure remission tried more than two
drugs before a later seizure control. However, it is known
that epilepsies are dynamic diseases and the response to
AEDs may vary throughout life without any external inter-
ference, possibly due to fluctuations inherent to its patho-
physiology3.
In this study, we divided MTLE patients who had failed at
least two different AEDs according to the seizure frequency
they presented throughout their life span. We opted in this
study for a restricted classification of patients and we con-
sidered the seizure frequency from the epilepsy onset.
Only patients who never experienced more than three CPS
per year and had no history of CTGS were classified as
infrequent seizures. Although the definition of what are
infrequent seizures is arbitrary and subjective, this dicho-
tomy of patients with high or low seizure frequency is com-
monly seen in the clinical practice. Patients with infrequent
seizures are not commonly submitted to epilepsy surgery
due to the low morbidity of the SPS or the scarce CPS.
The division of patients with the same epileptic syndrome
but with infrequent or frequent seizures might help the bet-
ter comprehension of the mechanisms of AED response.
An important aspect of our study is the patient sample.
Although our patients were selected in a tertiary epilepsy
centre, our service is composed by two different epilepsy
clinics, one for surgical candidates and other for those
who are not surgical candidates (non-surgical pathologies,
patients who declined surgery and those with infrequent sei-
zures or remission). Therefore, the complexity of the indivi-
duals in this study is possibly intermediate from what could
be expected in a population-based study or a study con-
ducted exclusively with patients of tertiary complexity.
In our study, we observed that nearly one-third of
MTLE-HS and MTLE-NL patients present a pattern of
relapse-remitting seizures and that the majority of patients
with this pattern remained with a low frequency of seizure
during the relapse periods. Three decades ago, Goodridge
and Shorvon noted an intermittent pattern of AED response
in which refractory seizures are interrupted by periods of
remissions of at least two years in 12% of their patients2.
Also, French et al. reported in a surgical series of adult
patients with MTLE that a quarter had experienced previous
periods of remission6. In our study, we observed higher
rates of relapse-remitting pattern in both MTLE-HS
and MTLE-NL. This variability of the frequency of relapse-
remitting patterns in different studies might be related to
the definition and extent of the remission period or the com-
plexity of the patients selected, which in our study was a
more broad population of MTLE cases. More importantly,
we observed that a relapse-remitting pattern in patients with
MTLE and a high frequency of seizures during the relapse
periods is not common and it is more often observed in
those with low frequency of seizures.
We did not observe differences in the frequency of infre-
quent or frequent seizures between MTLE-HS and MTLE-NL
patients. Equally, there was no significant difference of cur-
rent seizure remission between MTLE-HS and MTLE-NL.
This result differs from previous reports that observed
higher rates of AED resistant seizures in MTLE-HS than in
MTLE-NL12,13,14. In fact, in earlier studies, HS has been con-
sidered the epileptic pathology associated with the higher
rates of patients with AED resistant seizures4. Although HS
is classically associated with AED resistant seizures, in the
last decades, with easier and more widespread access to
MRI in non-surgical centres, it has been demonstrated
that signs of HS can also be observed in individuals with
infrequent seizures or seizure remission with or without
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AEDs15,16. However, the prevalence of HS in patients without
refractory seizures remains unclear16. In our study, 15% of
the patients with MTLE-HS were classified as having infre-
quent seizures and 11% were seizure-free for at least two
years. This is an important finding because it demonstrates
that in a more broad MTLE population, different from what
is commonly seem in tertiary epilepsy centres, MTLE-HS do
not have worse prognosis of seizure control than MTLE-NL.
Population studies with early detection of signs of HS in
patients with new onset epilepsies could demonstrate the
accurate rates of AED resistance in MTLE-HS.
Although great improvement has been achieved in
understanding the natural history of MTLEs in the last
decades there is still a lack of adequate longitudinal data
to confirm these findings. The difficulty to observe HS signs
in children with MTLE is one of the problems to conduct
longitudinal studies with MTLE-HS patients from the epi-
lepsy onset. Other difficulty is the adequate definition of
the epilepsy syndrome from the onset, which frequently
demands investments in complex and costly complementary
exams otherwise unnecessary for clinical treatment.
In conclusion, MTLE with or without MRI signs of HS
share some characteristics of AED response, as similar
rates of relapse-remitting pattern, which occurs more
often in patients with low seizure frequency during the
relapse periods.
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Table. Clinical characteristics of patients with MTLE-HS and MTLE-NL.
MTLE-HS (n = 122) MTLE-NL (n = 50) p
Sex 77 (63%) female 45 (37%) male 28 (56%) female 22 (44%) male X2, p = 0.385
Median age at MRI (range) 46 years (17-73) 43 years (19-74) Two-sample T-test, p = 0.251
Median number of AEDs
tried (range)
5 AEDs (2-9) 4 AEDs (2-9) Two-sample T-test, p = 0.057
Seizure onset (range) 12 years (0-50) 16 years (2-45) Two-sample T-test, p = 0.003
FS/IPI 13 (11%)/26 (22%) 3 (6%)/12 (25%) Fischer Exact Test, p = 0.402/p = 0.839
MTLE-HS: Mesial temporal lobe epilepsy with MRI signs of hippocampal sclerosis; MTLE-NL: Mesial temporal lobe epilepsy with normal MRI; n: Number of
patients; AED: Anti-epileptic drug; FS: Febrile seizure; IPI: Initial precipitating injury.
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